NH earnings

Q3 2022 Financial and Operational Highlights: Total net revenue was $16.6 million Gross profit was $9.7 million, or 58% of total revenue The company's Eviti Connect platform earned full URAC accreditation for Health Utilization Management, through 2025 Maryland Physicians Care signed a two-year renewal agreement for Eviti Connect for Autoimmune Diseases Post quarter end: Secured 3-year contract extension with large national commercial insurer that provides coverage to more than two million Medicaid members across multiple states. Expanded contract now includes formulary redirection NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help busi

NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2022 third quarter on Thursday, November 3, 2022, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company's performance. The conference call will be available to interested parties by dialing 800-942-2493 from the U.S. or Canada, or 212-231-2931 from international locations. The call will be broadcast via the Internet at www.nanthealth.com. About NantHealth, Inc. NantHealth, a member of the NantWorks ec

Q2 2022 Financial and Operational Highlights: Total net revenue was $16.5 million Gross margin was 55% of total revenue NantHealth products won three industry awards, one from MedTech Breakthrough and two from Spring Digital Health NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its second quarter ended June 30, 2022. "For the 2022 second quarter, we reported net revenue of $16.5 million, representing the third consecutive quarter of top-line growth," said Ron Louks, Chief Operating Officer, NantHealth. "We are pleased to note that our overall gro

NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2022 second quarter on Thursday, August 4, 2022, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company's performance. The conference call will be available to interested parties by dialing 800-771-6692 from the U.S. or Canada, or 212-231-2907 from international locations. The call will be broadcast via the Internet at www.nanthealth.com. About NantHealth, Inc. NantHealth, a member of the NantWorks eco

NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2022 first quarter on Thursday, May 5, 2022, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company's performance. The conference call will be available to interested parties by dialing 800-920-5526 from the U.S. or Canada, or 212-231-2907 from international locations. The call will be broadcast via the Internet at www.nanthealth.com. About NantHealth, Inc. NantHealth, a member of the NantWorks ecosyst

Q4 2021 Financial Highlights: Total revenue was $16.0 million Total gross margin was 57% Full-Year 2021 Financial Highlights: Total revenue was $62.6 million Total gross margin was 56% Operational Highlights: In Q4, signed and went live with Eviti Connect for Autoimmune Diseases program with Maryland Physician's Care (MPC), to provide digital drug authorizations for members living with autoimmune conditions In Q4, continued expansion of Eviti Connect for Oncology services provided through a key Eviti channel partner with the addition of the country's largest customer-owned health insurer In Q4, released the first OpenNMS Minion Appliance, a cloud-enabled, simple sol

NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2021 fourth quarter and full year on Thursday, February 24, 2022, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company's performance. The conference call will be available to interested parties by dialing 877-407-0312 from the U.S. or Canada, or 201-389-0899 from international locations. The call will be broadcast via the Internet at www.nanthealth.com. About NantHealth, Inc. NantHealth, a member of

Q3 2021 Financial Highlights: Total net revenue was $14.4 million Gross margin was 52% Cash of $45.5 million at September 30, 2021 Operational Highlights: Signed and preparing to launch first Eviti Connect program for autoimmune disease Achieved utilization management licensure/certification in six states enabling expansion of Eviti Connect to include fully delegated services In October, signed multi-year NaviNet Open agreement with third party administration service provider with potential to deploy provider portal capabilities to multiple new self-insured health plans Also in October, signed agreement with Care Continuity allowing parties to partner on product offerings

NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2021 third quarter on Thursday, November 4, 2021, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company's performance. The conference call will be available to interested parties by dialing 800-584-1507 from the U.S. or Canada, or 212-231-2902 from international locations. The call will be broadcast via the Internet at www.nanthealth.com. About NantHealth, Inc. NantHealth, a member of the NantWorks ec

Q2 2021 Financial Highlights: Total net revenue was $16.1 million Gross margin was 56% Completed $137.5 million financing transaction, extending maturity of debt and increasing cash position to $52 million at June 30 NaviNet AllPayer won Digital Health Award in Connected Digital category for enhancing digital payer transactions Post Quarter End: Announced appointment of Tiffany Avery, MD, MPH, as NantHealth's Chief Medical Officer   NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its second quarter ended June 30, 2021. "Our 2021 second-quarter

NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2021 second quarter on Thursday, August 5, 2021, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company's performance. The conference call will be available to interested parties by dialing 800-582-4096 from the U.S. or Canada, or 212-231-2918 from international locations. The call will be broadcast via the Internet at www.nanthealth.com. About NantHealth, Inc. NantHealth, a member of the NantWorks ecosystem o